CATHERINE GU: Open Payments
NPI 1073298634 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$786 in 31 payments from 9 companies in 2025. Trend: 2023 $157 · 2024 $625 · 2025 $786
Food & beverage: $786
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $372 |
| ANI Pharmaceuticals, Inc. | 5 | $108 |
| Kowa Pharmaceuticals America, Inc. | 5 | $79 |
| Lilly USA, LLC | 3 | $66 |
| Exact Sciences Corporation | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| ABBVIE INC. | 2 | $38 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Amgen Inc. | 1 | $17 |
Products named: Vemlidy, PURIFIED CORTROPHIN GEL, ZORYVE, Cologuard Collection Kit, KISUNLA, GARDASIL 9, MOUNJARO, UBRELVY.
Industry payments across NY — which companies pay providers there.
